Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Finkelstein

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
Chemical Science|August 21, 2018
Correction: Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
Chemical Science|February 17, 2018
Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
The Journal of Biological Chemistry|October 29, 2011
Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse modelCynthia P W Soon, Paul S Donnelly, Bradley J Turner, et al.
Acta Neuropathologica Communications|September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Neuron|July 11, 2008
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial AbetaPaul A Adlard, Robert A Cherny, David I Finkelstein, et al.
Acta Neuropathologica Communications|June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
The Journal of Experimental Medicine|April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's diseaseLin W Hung, Victor L Villemagne, Lesley Cheng, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
Chemical Science|August 21, 2018
Correction: Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
Chemical Science|February 17, 2018
Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
The Journal of Biological Chemistry|October 29, 2011
Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse modelCynthia P W Soon, Paul S Donnelly, Bradley J Turner, et al.
Acta Neuropathologica Communications|September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Neuron|July 11, 2008
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial AbetaPaul A Adlard, Robert A Cherny, David I Finkelstein, et al.
Acta Neuropathologica Communications|June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
The Journal of Experimental Medicine|April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's diseaseLin W Hung, Victor L Villemagne, Lesley Cheng, et al.
Pageof 25